Targeting TFPI With Concizumab to Improve Haemostasis in Glanzmann Thrombasthenia Patients: an in Vitro Study
Clinical trial NCT06234813 · COMPLETED
Trial details
- NCT number
- NCT06234813
- Sponsor
- University Hospital, Bordeaux
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-06
- Primary completion
- 2023-07-17
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.